Retinal organoids as a tool for in vitro pre-clinical testing

 IPSC-derived retinal organoids are an emerging in vitro tool for various applications
 They have a potential of being used in efficacy and safety screens of new compounds and for disease modelling applications
 They are increasingly showing utility in gene therapy applications and can be used for testing novel gene therapy vectors and investigating optimal doses, therapeutic potential and safety
 Newcells is making the organoids accessible by producing regular batches that can be shipped internationally